ZLTQ ZELTIQ Aesthetics Inc

INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Into Whether the Sale of ZELTIQ Aesthetics, Inc. to Allergan plc for $56.50 Per Share is Fair to Shareholders

NEW YORK--(BUSINESS WIRE)--

The following statement is being issued by Levi & Korsinsky, LLP:

To: All Persons or Entities who purchased ZELTIQ Aesthetics, Inc. (NASDAQ:ZLTQ) stock prior to February 12, 2017.

You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of ZELTIQ to Allergan plc (NYSE:AGN) for $56.50 per share. To learn more about the action and your rights, go to:

http://zlk.9nl.com/zeltiq

or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut, California, and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

EN
13/03/2017

Underlying

ZLTQZELTIQ Aesthetics Inc

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ZELTIQ Aesthetics Inc

 PRESS RELEASE
Free
ZLTQ ZELTIQ Aestheti...

INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Into ...

NEW YORK--(BUSINESS WIRE)-- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased ZELTIQ Aesthetics, Inc. (NASDAQ:ZLTQ) stock prior to February 12, 2017. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of ZELTIQ to Allergan plc (NYSE:AGN) for $56.50 per share. To learn more about the action and your rights, go to: http://zlk.9nl.com/zeltiq or contact Joseph E. Levi, Esq. eithe...

March 13, 2017 1 EN
 PRESS RELEASE
Free
ZLTQ ZELTIQ Aestheti...

ZELTIQ AESTHETICS (ZLTQ) SHAREHOLDER ALERT – Andrews & Springer LLC ...

WILMINGTON, Del.--(BUSINESS WIRE)-- Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential breach of fiduciary duty and securities violation claims against ZELTIQ Aesthetics, Inc. (NASDAQGS:ZLTQ) (“ZELTIQ” or the “Company”). If you currently own shares of ZELTIQ and want to receive additional information and protect your investments free of charge, please visit us at http://www.andrewsspringer.com/cases-investigations/zeltiq-aesthe...

March 13, 2017 1 EN
 PRESS RELEASE
Free
ZLTQ ZELTIQ Aestheti...

INVESTOR ALERT: Brower Piven Commences An Investigation Into The Propo...

STEVENSON, Md.--(BUSINESS WIRE)-- The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of ZELTIQ Aesthetics, Inc. (Nasdaq: ZLTQ) (“ZELTIQ” or the “Company”) relating to the proposed buyout of ZELTIQ by Allergan plc. Under the terms of the agreement, ZELTIQ shareholders are anticipated to receive $56.50 in cash for each share of ZELTIQ common stock held. The firm’s inves...

February 16, 2017 1 EN
 PRESS RELEASE
Free
ZLTQ ZELTIQ Aestheti...

ZELTIQ AESTHETICS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie ...

DALLAS--(BUSINESS WIRE)-- Former United States Securities and Exchange Commission attorney Willie Briscoe is investigating potential claims against the Board of Directors of ZELTIQ Aesthetics, Inc. (“ZELTIQ”) (NasdaqGS: ZLTQ) concerning the acquisition by Allergan plc. Under the terms of the agreement, valued at approximately $2.48 billion, ZELTIQ shareholders will only receive $56.50 per ZELTIQ share owned. The consideration is significantly lower than at least one analyst’s estimated value of $58.00 per share. If you...

February 14, 2017 1 EN
 PRESS RELEASE
Free
ZLTQ ZELTIQ Aestheti...

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Pr...

STEVENSON, Md.--(BUSINESS WIRE)-- The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of ZELTIQ Aesthetics, Inc. (Nasdaq: ZLTQ) (“ZELTIQ” or the “Company”) relating to the proposed buyout of ZELTIQ by Allergan plc. Under the terms of the agreement, ZELTIQ shareholders are anticipated to receive $56.50 in cash for each share of ZELTIQ common stock held. The firm’s inves...

February 14, 2017 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch